Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)
Christine Tagliaferri Rael*, Javier Lopez-Ríos, Stacey A. McKenna, Doyel Das, Curtis Dolezal, Elena Abascal, Alex Carballo-Diéguez, Rebecca Schnall, Thomas J. Hope, José Bauermeister, Walter Bockting
Dive into the research topics of 'Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)'. Together they form a unique fingerprint.